Jonathan Weitz

8PUBLICATIONS
51CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCellular interactions (incl. adhesion, matrix, cell wall)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 27, 2026
Metabolic Salvage and Acyl-chain Remodeling Support Glycosphingolipid Synthesis within the PDAC Tumor Microenvironment.

|Oct 16, 2024
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.

Jonathan Weitz, Daisuke Nishizaki, Joy Liau

|Jul 11, 2023
Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia.

Jonathan Weitz, Bharti Garg, Alexei Martsinkovskiy

|Jun 28, 2023
Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma.

Kevin Christian Montecillo Gulay, Xinlian Zhang, Vasiliki Pantazopoulou

|Jun 12, 2023
Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.

Deepak Rohila, In Hwan Park, Timothy V Pham

|Sep 06, 2022
An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape.

Jonathan Weitz, Tatiana Hurtado de Mendoza, Herve Tiriac

Pageof 2

Frequent Collaborators

5 joint publications

Andrew M Lowy

4 joint publications

Jay Patel

4 joint publications

Herve Tiriac

2 joint publications

Alejandro Caicedo